See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
0
0
$0.00
$0.00
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
No Insider Transactions found for Inhibitor Therapeutics, Inc.
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Dec 02, 2019 Hasara Garrison J. |
Hasara Garrison J.
CFO and Treasurer
|
Buy |
13,500 | $0.07 | 13,500 $0.07 $945 |
Aug 30, 2018 Hasara Garrison J. |
Hasara Garrison J.
CFO and Treasurer
|
Sell |
100,000 | $0.27 | 100,000 $0.27 $27,000 |
Jul 05, 2018 Mayne Pharma Ventures Pty Ltd |
Mayne Pharma Ventures Pty Ltd
|
Buy |
1,739,131 | $0.00 | 1,739,131 $0.00 $0 |
Jul 05, 2018 Mayne Pharma Ventures Pty Ltd |
Mayne Pharma Ventures Pty Ltd
|
Buy |
1,739,131 | $0.00 | 1,739,131 $0.00 $0 |
Jan 10, 2018 Mayne Pharma Ventures Pty Ltd |
Mayne Pharma Ventures Pty Ltd
|
Buy |
2,608,696 | $0.00 | 2,608,696 $0.00 $0 |
Jan 10, 2018 Mayne Pharma Ventures Pty Ltd |
Mayne Pharma Ventures Pty Ltd
|
Buy |
2,608,696 | $0.00 | 2,608,696 $0.00 $0 |
Dec 19, 2017 Mayne Pharma Ventures Pty Ltd |
Mayne Pharma Ventures Pty Ltd
|
Buy |
600,000 | $162,660.00 | 600,000 $162,660.00 $97,596,000,000 |
Dec 19, 2017 Cross Stefan |
Cross Stefan
|
Buy |
600,000 | $162,660.00 | 600,000 $162,660.00 $97,596,000,000 |
TOP